March 2024: Paul Jessup disqualified after fund misappropriation

One clear story from March 2024: Paul Jessup, the former managing director of Strand Capital SA, has been disqualified from acting as a company director for nine years. The Insolvency Service found he misused money from Helvetica Investments Ltd, leaving the business with a major shortfall. If you follow corporate news in the pharma world, this case matters because it shows how weak controls and bad judgment can hurt companies and customers alike.

What happened

According to the Insolvency Service, Jessup used funds belonging to Helvetica Investments Ltd in ways he shouldn’t have. That misuse created a significant financial gap that the business couldn’t cover. The regulator’s response was a nine-year ban on serving as a company director. The headline is simple: the regulator held an individual accountable for mismanaging investor funds.

How this matters for directors and investors

If you run a company, this is a reminder that governance matters as much as product quality. For directors, it’s not enough to be experienced or well-connected. You must keep clear records, separate client or investor money from company cash, and follow reporting rules. Regulators will act when they find misuse or poor oversight.

As an investor, ask direct questions about where money is held and who can access it. Check audit trails, independent oversight, and whether managers are properly licensed or insured. If a fund or firm can’t show clean accounting, walk away. Small red flags—missing statements, slow answers, or inconsistent records—often point to bigger problems.

This case also affects trust. When a fund manager is banned, it shakes confidence in similar firms. That can slow investment and complicate funding for companies that actually follow the rules. In health and pharma, where funding supports drug development and supply chains, shaky governance can slow product launches or disrupt access to medicines.

What should you do if you run a small healthcare company or manage investor money? First, keep transparent accounting and regular audits. Second, set clear limits on who can move funds and require dual approvals for big transfers. Third, document decisions and keep minutes. These steps don’t cost much but they reduce risk dramatically.

If you’re simply following the industry, this story is a good prompt to check the firms you trust. Look for up-to-date regulatory records and director histories. A quick check can reveal past sanctions or warnings that matter to your investments or the stability of a supplier.

March 2024’s coverage on Exact-Pharma highlighted accountability and the practical steps businesses should take to protect money and reputation. Keep this case in mind when you evaluate companies, investments, or partners—good governance protects patients, investors, and the long-term health of the industry.

Former Strand Capital Managing Director Paul Jessup Disqualified for Fund Misappropriation

Former Strand Capital Managing Director Paul Jessup Disqualified for Fund Misappropriation

Paul Jessup, the ex-managing director of Strand Capital SA, has been disqualified from serving as a company director for nine years. The Insolvency Service found him guilty of misusing funds from Helvetica Investments Ltd, leading to a significant financial shortfall and his subsequent disqualification.

RECENT POSTS

May 25, 2025
Clomid: Everything You Need to Know About Fertility and Beyond

Clomid, known for helping with ovulation, is a go-to fertility drug for women and can help men, too. This article breaks down how Clomid works, who it’s for, what to expect, and the real-life experiences that come with it. If you’re curious about side effects, success rates, or want some tips for making treatment smoother, you’ll find answers here. We explore both science and stories, so you walk away with practical, real-world info. No dry medical talk—just honest facts.

March 22, 2024
Former Strand Capital Managing Director Paul Jessup Disqualified for Fund Misappropriation

Paul Jessup, the ex-managing director of Strand Capital SA, has been disqualified from serving as a company director for nine years. The Insolvency Service found him guilty of misusing funds from Helvetica Investments Ltd, leading to a significant financial shortfall and his subsequent disqualification.

October 12, 2025
How Hydration Stops Motion Sickness - Simple Science & Tips

Discover how proper hydration stabilizes the inner ear, reduces nausea, and keeps motion sickness at bay. Get practical water‑drinking schedules, fluid choices, and extra tips for comfortable travel.

May 13, 2023
Cephalexin for Preoperative Prophylaxis: Reducing the Risk of Infection

As a blogger, I recently came across an interesting topic regarding the use of Cephalexin for preoperative prophylaxis. It's amazing to learn that this antibiotic can significantly reduce the risk of infection during surgery. By taking Cephalexin before a procedure, patients can prevent potential complications and ensure a smoother recovery. This is definitely an important measure to consider for those undergoing surgery. I'm glad to have discovered this valuable information and will continue to share such useful findings with my readers.

May 13, 2023
The Use of Nerve Blocks and Injections in Trigeminal Neuralgia Treatment

In my latest research, I discovered that nerve blocks and injections are becoming increasingly popular in the treatment of trigeminal neuralgia. This condition is characterized by severe facial pain, and these treatments provide temporary relief by numbing the affected area. I learned that doctors often use nerve blocks as a diagnostic tool to pinpoint the source of pain and to determine the most effective treatment plan. Additionally, injections such as Botox and steroid injections can help reduce inflammation and alleviate pain. Overall, these treatments offer a promising alternative to medications and surgical procedures for individuals suffering from trigeminal neuralgia.